Literature DB >> 12175085

Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a university children's hospital.

Christine Papadea1, Joyce Foster, Sharon Grant, Sandra A Ballard, John C Cate, W Michael Southgate, Dilip M Purohit.   

Abstract

We evaluated the analytical performance of the i-STAT Portable Clinical Analyzer (PCA), a point-of-care testing system consisting of a hand-held analyzer and single-use cartridges that measure different panels of electrolytes, metabolites, blood gases, and hematocrit in 65-100 microl of blood. Our objective was to determine whether PCA measurements at the bedside of patients in the neonatal and pediatric intensive care units of the MUSC Children's Hospital would be as reliable as those performed by the clinical laboratory's primary methods (Radiometer ABL 725 blood gas analyzer; Vitros 750 chemistry analyzer; and Coulter STKS hematology analyzer). Four cartridge types: (a) EC8+ (sodium; potassium; chloride; urea; glucose; pH; blood gases [PO2; pCO2]), (b) EC6+ (sodium; potassium; ionized calcium; glucose; hematocrit; pH), (c) G3+ (pH; PO2; pCO2), and (d) creatinine, were assessed for reproducibility, linearity, and method comparisons using aqueous samples, blood samples supplemented with several analytes, and -225 blood samples from patients. Reproducibility (CV) was good (< 2%) for electrolytes, glucose, urea, and pH, satisfactory (< 6.5%) for blood gases and creatinine, but poor (21%) for hematocrit. Linearity concentrations spanning the clinically relevant ranges were verified for all analytes. Method comparison studies with samples separated into 2 subgroups by patient age (> or < 3 mo) showed that agreement between the PCA and the primary methods was clinically acceptable. After the PCA was implemented for clinical testing, the observation of discrepant results of creatinine concentrations in neonatal blood samples that would have affected clinical management led to a second creatinine comparison study (59 additional samples) and to our eventual discontinuation of the PCA creatinine assay. This problem notwithstanding, the successful implementation of the PCA is attributed to careful analytical evaluations and ongoing communication with the clinical staff.

Entities:  

Mesh:

Year:  2002        PMID: 12175085

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  14 in total

Review 1.  Microelectromechanical systems and nephrology: the next frontier in renal replacement technology.

Authors:  Steven Kim; Shuvo Roy
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

Review 2.  Advances in microfluidic materials, functions, integration, and applications.

Authors:  Pamela N Nge; Chad I Rogers; Adam T Woolley
Journal:  Chem Rev       Date:  2013-02-14       Impact factor: 60.622

3.  A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.

Authors:  Steven Fishbane; Martin Ford; Masafumi Fukagawa; Kieran McCafferty; Anjay Rastogi; Bruce Spinowitz; Konstantin Staroselskiy; Konstantin Vishnevskiy; Vera Lisovskaja; Ayman Al-Shurbaji; Nicolas Guzman; Sunil Bhandari
Journal:  J Am Soc Nephrol       Date:  2019-06-14       Impact factor: 10.121

4.  Evaluation of the i-STAT point-of-care analyzer in critically ill adult patients.

Authors:  Jacoline Steinfelder-Visscher; Steven Teerenstra; Jacqueline M T Klein Gunnewiek; Patrick W Weerwind
Journal:  J Extra Corpor Technol       Date:  2008-03

Review 5.  Point-of-care diagnostics for niche applications.

Authors:  Brian M Cummins; Frances S Ligler; Glenn M Walker
Journal:  Biotechnol Adv       Date:  2016-02-01       Impact factor: 14.227

Review 6.  Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.

Authors:  Catherine E Majors; Chelsey A Smith; Mary E Natoli; Kathryn A Kundrod; Rebecca Richards-Kortum
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

Review 7.  Strategies to improve neurodevelopmental outcomes in babies at risk of neonatal hypoglycaemia.

Authors:  Jane M Alsweiler; Deborah L Harris; Jane E Harding; Christopher J D McKinlay
Journal:  Lancet Child Adolesc Health       Date:  2021-04-06

8.  Risk factors for late-onset hyponatremia and its influence on neonatal outcomes in preterm infants.

Authors:  Yoon-Joo Kim; Jin A Lee; Sohee Oh; Chang Won Choi; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

Review 9.  The state of point-of-care testing: a European perspective.

Authors:  Anders Larsson; Roman Greig-Pylypczuk; Albert Huisman
Journal:  Ups J Med Sci       Date:  2015-01-26       Impact factor: 2.384

10.  Raised HIF1α during normoxia in high altitude pulmonary edema susceptible non-mountaineers.

Authors:  Poonam Soree; Rajinder K Gupta; Krishan Singh; Koundinya Desiraju; Anurag Agrawal; Praveen Vats; Abhishek Bharadwaj; T P Baburaj; Pooja Chaudhary; Vijay K Singh; Saroj Verma; Amir Chand Bajaj; Shashi Bala Singh
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.